HME News: The American Academy of Sleep Medicine and other professional organizations are making the case to CMS and private payors that the 90-day adherence rule for PAP therapy should be temporarily suspended in the wake of the Philips recall.
“Given that many patients will be affected by the recall, we are requesting support from CMS and private payers to temporarily suspend the 90-day adherence rule to allow patients to have existing equipment repaired or receive new equipment from DME suppliers,” the letter states.
The American Academy of Neurology, the American College of Chest Physicians, the American Thoracic Society, the Alliance of Sleep Apnea Partners and the American Sleep Apnea Association joined the AASM in sending the letter to CMS and private payers.
The groups also make the case for CMS making an exception to the RUL requirements for the equipment repairs or replacements that will result from the recall.
